Detalles de la búsqueda
1.
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Lancet Oncol
; 19(11): 1504-1515, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30316827
2.
Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413.
Cancer
; 119(11): 1999-2004, 2013 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23504930
3.
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.
Int J Radiat Oncol Biol Phys
; 112(1): 83-92, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34919884
4.
Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.
Ann Nucl Med
; 32(8): 553-560, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30094545
5.
Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.
Int J Radiat Oncol Biol Phys
; 92(2): 228-35, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25847605
6.
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.
J Clin Oncol
; 33(4): 332-9, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25534388
7.
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.
Int J Radiat Oncol Biol Phys
; 76(2): 361-8, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19394158
Resultados
1 -
7
de 7
1
Próxima >
>>